SPARC upregulates MT1-MMP expression, MMP-2 activation, and the secretion and cleavage of galectin-3 in U87MG glioma cells
- 1 May 2007
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 419 (2) , 172-177
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Cleavage at the stem region releases an active ectodomain of the membrane type 1 matrix metalloproteinaseBiochemical Journal, 2005
- Alterations in Galectin-3 Expression and Distribution Correlate with Breast Cancer ProgressionThe American Journal of Pathology, 2004
- Microregional extracellular matrix heterogeneity in brain modulates glioma cell invasionThe International Journal of Biochemistry & Cell Biology, 2004
- International hermelin brain tumor symposium on matricellular proteins in normal and cancer cell-matrix interactionsMatrix Biology, 2004
- Bone-related Genes Expressed in Advanced Malignancies Induce Invasion and Metastasis in a Genetically Defined Human Cancer ModelJournal of Biological Chemistry, 2003
- Roles of membrane type 1 matrix metalloproteinase and tissue inhibitor of metalloproteinases 2 in invasion and dissemination of human malignant gliomaJournal of Neurosurgery, 2001
- Galectins Are Differentially Expressed in Supratentorial Pilocytic Astrocytomas, Astrocytomas, Anaplastic Astrocytomas and Glioblastomas, and Significantly Modulate Tumor Astrocyte MigrationBrain Pathology, 2001
- Expression and Tissue Localization of Membrane-Type 1, 2, and 3 Matrix Metalloproteinases in Human Astrocytic TumorsThe American Journal of Pathology, 1999
- Galectin-3 Is a Novel Substrate for Human Matrix Metalloproteinases-2 and -9Biochemistry, 1994
- SPARC, a secreted protein associated with morphogenesis and tissue remodeling, induces expression of metalloproteinases in fibroblasts through a novel extracellular matrix-dependent pathway.Journal of Cell Biology, 1993